Relative to emergency stock epinephrine in schools
Summary
This bill requires every school in Massachusetts to maintain a stock supply of non-patient-specific epinephrine auto-injectors for use in an anaphylactic emergency. It directs the Department of Public Health to issue regulations requiring school districts to adopt policies for storing the medication in an easily accessible unlocked location, determining the number and type of auto-injectors based on school population, training authorized staff to administer epinephrine, and checking inventory regularly for expiration and replacement.
The bill also provides civil liability protection for school nurses and other authorized school employees who, in good faith, provide or assist with epinephrine administration to a student believed to be having an anaphylactic reaction. If the employee is covered by that immunity, the school district is also shielded from negligence liability for those acts or omissions. In addition, the Department of Public Health and the Department of Elementary and Secondary Education must make reasonable efforts to secure federal funding or reimbursement and inquire about obtaining free epinephrine from pharmaceutical companies.
Impact
The bill would amend Section 54B of chapter 71 of the General Laws, expanding school health requirements by mandating stock epinephrine in all schools and authorizing DPH to regulate implementation statewide. It would affect school districts, school nurses, and other trained school personnel by imposing storage, training, inventory, and administration requirements, while also creating statutory immunity for emergency use of epinephrine and extending that protection to employing school districts.
Sentiment
The available context suggests generally favorable support for the bill, with no recorded committee transcript opposition or votes in the provided materials. The filing includes multiple cosponsors, and the measure appears to be a refiled version of similar legislation from a prior session, which typically indicates continuing interest in the policy. Overall, the bill is framed as a student safety and emergency preparedness measure.
Contention
The main policy issues likely involve implementation details rather than the core concept of stock epinephrine. Potential points of contention include the cost of purchasing and replacing auto-injectors, how many devices each school must keep, who should be authorized and trained to administer them, and whether schools can reliably store the medication in an unlocked but secure location. The bill attempts to address cost concerns by directing state agencies to seek federal reimbursement and free product from manufacturers, and it addresses liability concerns by granting immunity to staff and districts acting in good faith.